Venous thromboembolic events: How low can you go?

Am J Surg. 2017 Apr;213(4):706-710. doi: 10.1016/j.amjsurg.2016.10.037. Epub 2017 Jan 13.

Abstract

Background: We evaluated postoperative venous thromboembolism (VTE) chemical prophylaxis adherence to assess the preventability of VTEs.

Methods: A case-control study was performed using the 2011-2015 ACS-NSQIP single institution database. Cases were identified as patients who experienced postoperative VTE within 30 days following surgery. Controls were matched 2:1 on procedure, age, and BMI. Association between inpatient chemical prophylaxis adherence and postoperative VTE was evaluated with conditional logistic regression.

Results: Seventy-three cases were matched to 145 controls. Complete inpatient VTE chemical prophylaxis adherence did not differ between cases and controls (45.2% vs. 46.2%, p = 1.00). Odds of postoperative VTE increased if a patient's prophylaxis was interrupted (OR 6.34, 95% CI 1.82-22.13). However, 53.7% of instances of interrupted prophylaxis were medically justified by concern for bleeding, spine operation, or for additional upcoming procedure.

Conclusions: Nearly half of patients who experienced postoperative VTEs received appropriate guideline-driven care. Most interruptions in chemical prophylaxis were justified medically. This further questions the preventability of postoperative VTEs and the utility of this outcome as a valid measure of hospital quality.

Keywords: DVT; NSQIP; Preventability; Thromboembolism; VTE.

MeSH terms

  • Anticoagulants / therapeutic use*
  • Case-Control Studies
  • Enoxaparin / therapeutic use
  • Female
  • Guideline Adherence / statistics & numerical data*
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications / prevention & control*
  • Practice Guidelines as Topic*
  • Quality Assurance, Health Care
  • United States
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / prevention & control*

Substances

  • Anticoagulants
  • Enoxaparin